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Environmental or nutritional estrogenic toxicants are thought to mediate developmental and carcinogenic pathologies. Estrogen receptor (ER)
measurements are currently used to predict hormonal responsiveness; therefore all ER subpopulations should be considered. We have been
involved in the immunoidentification and characterization of membrane steroid receptors in several systems and have recently shown that binding
of estradiol (E2) to a subpopulation of ERs (mER) residing in the plasma membrane of GH3 pituitary tumor cells mediates the rapid release of
prolactin (PRL). Here we review these findings and present other important characterizations of these receptors such as trypsin and serum
susceptibility, movement in the membrane, confocal localization to the membrane, binding to and function of impeded ligands, and
immunoseparation of cells bearing mER. We plan to use this system as a model for both the physiological and pathological nongenomic effects of
estrogens and estrogenic xenobiotics. Specifically, it should be useful as an in vitro assay system for the ability of estrogenic xenobiotics to cause
rapid PRL release as an example of nongenomic estrogen effects. - Environ Health Perspect 103(Suppl 7):41-50 (1995)
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Introduction
There are many known instances of estro-
gen toxicity that affect development and
function of reproductive systems in
humans and animals (1,2). Estrogen has
been shown to have a role in initiating dis-
eases (induding cancer) in a variety of tis-
sues (3-5). As more sensitive assays for
estrogen receptors (ERs), their mRNAs,
and their functions become available (6),
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more tissues will be considered for these
actions by estrogens. Understanding the
toxicity of estrogen and the myriad syn-
thetic and naturally occurring estrogenic
compounds (1,2,7) requires an under-
standing ofwhether their effects are being
mediated through genomic or nongenomic
mechanisms.
The genomic actions of estrogens and
other steroid hormones are now relatively
well understood. In this pathway, hor-
mones, bind to a cytoplasmic/nuclear
receptor, which binds to DNA and triggers
RNA-dependent protein synthesis (8,9).
However, this mechanism best explains
temporally delayed effects because it
requires a series ofmacromolecular synthe-
ses and protein localizations to produce
responses over time periods ofseveral hours
to days (10). Steroids and their mimetics
also exert a variety of short-term effects
(seen in seconds to minutes) on their target
organs. For example, estradiol (E2) rapidly
affects monovalent and divalent cation
transport, glucose uptake, and water imbi-
bition in the rat uterus (11). In neurons
and GH3 pituitary tumor cells, estrogens
can elicit changes in electrical activity
within minutes (12-16). A fast action of
estrogen mediates calcium mobilization in
granulosa cells (17) and osteoblasts (18).
Rapid electrical responses to estrogens also
occur in several areas ofthe brain and other
tissues (15,16,18-23). Many fast or other-
wise mechanistically unexplained actions of
other steroids have also been reported
(17,24-35). Plasma membrane-resident
forms of steroid receptors have been pro-
posed to mediate such actions (36,37).
Although the action ofa membrane-res-
ident steroid receptor is implied in the sys-
tems described above, only some of these
studies actually attempted to demonstrate
the presence ofsuch a protein in the mem-
brane. Several groups have provided evi-
dence for the binding oflabeled steroid to a
membrane-associated site (29,36-42). We
have developed techniques that rely mainly
on the immunological detection and isola-
tion of steroid hormone receptors residing
in plasma membranes (43-48). We used
these antibody (Ab) labeling techniques to
demonstrate membrane glucocorticoid
receptor (mGR) in both mouse and human
lymphoma cell lines and to correlate the
mGR's presence with the dinically impor-
tant lymphocytolytic response ofthese cells
to glucocorticoids. The collective presence
offunctional domains that mediate steroid
binding, multiple epitope recognition, and
DNA binding (49) suggests that mGR is
closely related to the already characterized
intracellular glucocorticoid receptor and is
not an entirely different protein. A mem-
brane location for the initiation ofcytolysis
may be related to changes in membrane
permeability and the calcium activation of
degradative enzymes (50), and these mech-
anisms mayhave relevance for other nonge-
nomic actions ofsteroids. We have recently
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applied these procedures to the related
problems of demonstrating a membrane
receptor for estrogens in the membrane of
pituitary tumor cells and correlating mem-
brane ER (mER) expression in subclones of
these cells to their ability to rapidly secrete
prolactin (PRL) (48).
Methods
Cells andGrowth Conditions
GH3/B6 cells (provided by Bernard Dufy)
were routinely cultured in a serum-supple-
mented medium (SSM) composed of
Ham's F-10 (Gibco-BRL, Gaithersburg,
MD) supplemented with 12.5% heat-inac-
tivated horse serum (Gibco-BRL) and
2.5% heat-inactivated defined/supple-
mented bovine calf serum (Hyclone Labs,
Logan, UT). Our defined medium (DM1)
is adapted from Hayashi and Sato (51),
but uses phenol red-free RPMI 1640
(Gibco-BRL) because phenol red is known
to be a weak estrogen (52). The medium is
supplemented with insulin (10 pg/ml;
Boehringer Mannheim, Indianapolis, IN),
bovine transferrin (5 1ig/ml; Boehringer
Mannheim), parathyroid hormone (bovine
1-34, 0.5 ng/ml; Bachem, Torrance, CA),
3,3',5-triiodothyronine (3 x 10-11M;
Sigma Chemical Co, St. Louis, MO), thy-
rotropin-releasing hormone (1 ng/ml;
Bachem), and fibroblast growth factor
(1 ng/ml; Boehringer Mannheim).
Before PRL release experiments, cells
were subcultured for 2 to 4 days in DM1.
Cells growing exponentially in SSM were
washed once with phosphate-buffered
saline (PBS) and trypsinized (0.5% trypsin,
0.5 mM EDTA in Hank's balanced salts
solution; Sigma) for 3 min. The trypsin
was quenched with SSM and cells were
centrifuged at 125xg for 5 min. The cells
were then washed once with PBS, resus-
pended in DM1, and plated onto poly-D-
lysine (180,000 mw; Sigma)-treated 6-well
(35 mm) plates. All dishes were seeded
from a single resuspension ofcells to assure
an equal cell number in each well.
Immunocythemisty
Cells in the exponential growth phase were
removed from the culture flask with
trypsin (0.5% w/v trypsin, 0.5 mM EDTA
in Hank's balanced salts solution), then
treated with SSM or soybean trypsin
inhibitor (0.1% w/v in PBS). Round cov-
erslips 12 mm in diameter (Baxter,
McGaw Park, IL) were placed in the wells
ofa 24-well tissue culture plate and treated
with poly-D-lysine (Sigma). Cells were
seeded onto these coverslips in DM1
supplemented with 10 pM E2 (E2 added at
this low level maintains basic estrogen-
responsive systems such as PRL synthesis at
levels comparable to SSM cultured cells)
(53) and subcultured for 2 days.
For live-cell immunolabeling, DM1
was aspirated from the cells and replaced
with PBS at 370C, then the 24-well plate
containing the cells on the coverslips was
placed in a tray on an ice-water bath and
allowed to cool for 45 min. The ice-water
bath registered a constant 2°C. The cells
were then washed 3 times in PBS with 1%
(w/v) bovine serum albumin (1% phos-
phate-buffered saline with 1% bovine
serum albumin [PBSA]; Fraction V, Sigma).
Both affinity-purified anti-ER antibod-
ies (R3 and R4), characterized by Pappas et
al. (48), were used at a dilution of 1:100
(Ab:1% PBSA) for immunocytochemical
procedures. For live cell immunocyto-
chemistry, primary Ab, secondary Ab
(Cy3-conjugated goat anti-rabbit IgG;
Jackson ImmunoResearch Laboratories,
West Grove, PA) and 4% (v/v) normal
goat serum (Jackson ImmunoResearch
Laboratories) were diluted in 1% PBSA and
preincubated for 1 hr at 2°C. A rabbit poly-
clonal anti-actin Ab was obtained from
ICN ImmunoBiologicals (Lisle, IL). The
coverslips with cells attached were inverted
onto 10 fd of the Ab mixture for 20 min,
then washed, fixed with 4% (w/v) para-
formaldehyde for 10 min, and mounted
with 20% (v/v) glycerol in PBS. In experi-
ments involving trypsin sensitivity of the
mER antigen, cells were washed once with
PBS, then treated at 22°C for 10 min with
5 pg/ml bovine pancreatic trypsin (Type
A
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III; Sigma). The trypsin was quenched with
1% PBSA for 10 min. The cells were then
washed 2 times in 1% PBSA and processed
as above for live cell labeling. In membrane
mobility patching-and-capping experi-
ments, cells were warmed to 37°C for 20
min afterAb application and then cooled to
2°C for the remainingwashes and fixation.
Cells were viewed on a Zeiss fluores-
cence microscope using a 63X oil immer-
sion Planapo lens and rhodamine filter,
except where indicated. The amount of
time for a metered exposure of a positive
response was used as a standard for subse-
quent photographs of negative controls.
Photomicrographs were taken with T-MAX
400 film (Eastman Kodak, Rochester, NY).
PRLRdease in Response
toE2 andE2-BSA
170-E2 (Sigma) was diluted in ethanol to a
1 mM concentration; a further dilution
was made in phenol red-free RPMI 1640
supplemented with 25 mM HEPES. The
final concentration ofethanol was 0.001%.
1,3,5(10) Estratriene-3,17P diol 6-one
6-carboxymethoxime: BSA (E2-BSA) was
obtained from Steraloids (Wilton, MA).
The ratio ofestrogen to BSA in this prepa-
ration was 15 to 20:1. The conjugate was
dissolved in deionized water to a concen-
tration of 1 mg/ml then treated with
dextran/charcoal (0.5%/5% in PBS)
immediately before dilution to remove free
steroid. Subsequent dilutions were made in
phenol red-free RPMI 1640 supplemented
with 25 mM HEPES.
For the PRL release assays depicted in
Figure 1, cells were subcultured for 2 to 5
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Figure 1. E2 conjugated to BSA causes rapid release of PRL. (A) Time course of 5 ng/ml E2-BSA-stimulated PRL
release. n=12 for 1 min time point; n=6 for 5 min time point. Data are from three experiments. (B) Dose-related
effects of the conjugated steroid presented for 1 min at indicated concentrations. n28 for all doses except
1DD ng/ml (n=5); data are from two experiments. Data are expressed as percent of the mean of the 1 min control.
A two-way ANOVA revealed a significant effect of ligand treatment (f=9.23; df=1, 32; p<0.05) and time (f=4.41;
df=1, 32; p<0.05) on PRL release. Error bars are SEM. Control, BSA alone. *Significantly different from control
(P<0.05).
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days in DM1. All experiments were done at
370C. Each well was washed 3 times in
serum-free phenol red-free RPMI 1640
supplemented with 25 mM HEPES, pH
7.4. The cells were then preincubated in
this medium on an orbital shaker for 30
min to allow sufficient PRL accumulation
in the medium for accurate radioim-
munoassay (RIA) determinations (sufficient
signal to fall within the detection level and
the standard curve). Medium containing
steroid or ethanol (vehicle control) was then
added to dishes for the desired experimental
exposure time. The supernatant was then
transferred to a chilled microcentrifuge tube
and centrifuged at 800xg for 5 min to
remove cells that came offthe plate during
the experiment. The supernatant was aspi-
rated into a clean microcentrifuge tube and
stored at -200C until assayed.
Alternatively, instead of allowing 30
min for accumulation of PRL into the
media, higher numbers ofcells were passed
to plates and the 30-min preincubation
was eliminated (Figures 2,3). Then, steroid
orvehicle treatments in rat saline (150 mM
NaCl, 5.6 mM KCI, 2 mM CaCl2, 1 mM
MgCI2, 10 mM HEPES, pH 7.35, and 10
mM glucose) were added to the well for
the specified amount oftime. There was no
significant difference in the magnitude of
stimulated release in these two paradigms.
Because larger numbers of cells were used
in these assays, the secreted PRL level was
measurable without a preincubation-accu-
mulation ofhigher levels ofhormone.
The concentrations of PRL in the
media were determined by RIA (54) using
a kit provided by the National Institute of
Diabetes and Digestive and Kidney Disease
and the National Hormone and Pituitary
Program (University of Maryland School
of Medicine, award no. 29196 to T.
Pappas and C. Watson). Ab-bound PRL
was separated using a goat anti-rabbit sec-
ondary Ab (Chemicon, El Segundo, CA)
precipitated with 10% (w/v) polyethylene
glycol (8000 mw, Sigma). All samples were
assayed in duplicate. Data were normalized
by dividing by the mean ofthe control and
statistical analyses were performed on SYS-
TAT version 3.0 (Systat Inc., Evanston,
IL) using the MGLH module. Post hoc
group differences were analyzed with
Scheffe's multiple contrast (55). Statistical
significance was accepted atp<0.05.
The trypsin treatment affecting E2-
induced PRL release was performed as
above for immunocytochemical studies.
The reaction was stopped with soybean
trypsin inhibitor (1 mg/ml) for 5 min fol-
lowed by three washes with rat saline. After
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Figure 2. Trypsin removal of mER abolishes the PRL
release response to estrogen. RIA measurements of
released PRL after 5-min treatment of mER+ cells. Data
are from two independent experiments; n=7 for each
group. Each value is expressed as a percentage of its
own control (no E2) value. Error bars show SEM. *Sig-
nificantly different from control atthe p<0.05 level.
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Figure 3. Enhancement of the rapid PRL release
response in mER-enriched cells. Each E2-treated group
is compared to its own control. *Significantly different
from the paired control atthe p<0.05 level.
a 30-min preincubation in rat saline, cells
were treated with 10 nM 17P-E2 or vehicle
(0.001% ethanol) for 5 min. Supernatants
were assayed for PRL as above.
immunoselection of
mER-bearingCells
Culture-dish wells were prepared for
immunopanning by sterile-filtering affinity
purified Ab (1 mg/ml) in 0.1% PBSA into
them, allowing Ab to attach to the plate at
370C for 2 hr, chilling to 40C, and rinsing
once with chilled PBS. Because trypsin
removes mER, we explored other means to
prepare cells for immunopanning. Approx-
imately 106 GH3/B6 cells, grown in DM1
for 48 hr, were removed from the plate
with a nonenzymatic cell dissociation solu-
tion with no Mg2+ or Ca2+ (Sigma). The
cells were washed, resuspended in PBS
+0.1% BSA (fatty acid-free), and rocked
for 1 hr at 370C to allow turnover and
repair of membranes. The cells were then
chilled to 40C and seeded onto a well con-
taining the attached Ab. The Ab-coated
dish with added cells was placed onto an
ice bath for 1 hr on an orbital shaker.
Unattached cells were then aspirated from
the plate and saved as the (-) or depleted
fraction. The plate, still containing the
enriched or (+) fraction, was rinsed once
with chilled PBS, and 1 ml SSM was put
onto the cells. Cells were gently triturated
from the well, amplified using routine cul-
ture procedures, and switched to DM1 for
2 days before processing for immunocyto-
chemistry (exceptwhere indicated).
Results and Discussion
MembranellizationoftheER
A membrane localization has been demon-
strated for a subpopulation of cellular ER
based on live-cell labeling techniques. The
Ab is unable to enter the cell through
intact plasma membranes, and cold incu-
bation temperatures prevent endocytosis
during the labeling procedure. The punc-
tate appearance ofthe ER membrane anti-
gen shown in Figure 4A appears on only 8
to 17% ofthe cells (48).
Other membrane-resident steroid
receptors have been shown to be attached
to the plasma membrane in such away that
exposure of intact cells to mild trypsin
treatment removed the antigen from the
cell surface (43,46). To further examine
the possibility of cell surface localization
for ER, we subjected live cells to mild
trypsin digestion and checked for the pres-
ence ofantigen. This treatment resulted in
complete elimination of surface ER
immunoreactivity (Figure 4C) and shows
that the ER membrane labeling depends
on the integrity of membrane proteins.
Because trypsin has no access to the intra-
cellular receptors, this action supports an
outer-face plasma membrane localization.
This also confirms the utility ofAb-based
identification techniques for this class of
steroid receptors, as we have shown previ-
ously for mGR (43-46).
Often, mER labeling was not evenly
distributed over the surface of the cell.
Examples of such asymmetric Ab staining
can be seen in Figures 4A, 5B, and 6A,B,
where staining is sometimes over one pole
of a cell or in patches. A more extremely
restricted distribution oflabeling is seen in
Figure 4E, where the cells were incubated
at 37°C for 20 min after Ab addition. The
photomicrograph shows representative fea-
tures such as label coalescing into patches
and accumulating on one side of the cell,
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Figure 4. The membrane ER antigen is punctate in appearance, can be digested away by mild trypsin treatment, and undergoes asymmetric redistribution at 37°C. (B), (D),
and (F) are the phase contrast images of the fluorescence micrographs shown in (A), (C), and (E). (A) shows the punctate appearance of the membrane ER antigen labeled
with affinity-purified R3 Ab; note that not all cells are labeled (compare to B, arrows). (C) shows a fluorescence micrograph of cells that were treated for 10 min with trypsin,
then labeled with the affinity-purified R4Ab. (E) shows the appearance of mER afterthe cells have been incubated with labeled R4 Ab for 20 min at37°C. Bars = 10 pm.
as well as a general reduction in the number
ofcells showing label. We do not presently
know if the lost label is endocytosed or is
sloughed from the cell. Movement ofanti-
gen on the cell surface, resulting in patch-
ing and capping of the Ab-antigen
complex, has been described for other
membrane antigens (56,57) as well as for
the mGR (43,44,46). This mobility may
be part ofthe process ofcellular uptake or
sloughing ofthe antigen-Ab complex and,
in some cases, may be important for the
function of the surface protein, e.g.,
growth factor receptors (57,58).
Confocal laser microscopy is an alterna-
tive technique for establishing cellular
localization ofa protein by optical section-
ing through a fluorescently labeled cell. We
demonstrated a membrane location for the
ER with these techniques (Figure 5). Note
again the punctate appearance ofthe cell in
Figure 5A and the asymmetric mER distri-
bution, especially pronounced in the cell in
Figure 5B. The uneven topology of these
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Figure 5. Confocal localization of mER to the plasma
membrane with R3 Ab. Optical sections were taken at
1.5 pm (A) or 1.3 pm (B) intervals through the entire
thickness of the cell. Frame #1 shows the part of the
cell that was attached to the coverslip.
cells (especially in Figure 5A) gives the
appearance of signal being present deeper
in the cell. However, our labeling tech-
niques preserve the integrity of the plasma
membrane and do not allow endocytosis
during the course of the experiment, thus
assuring us that the labeling seen is on the
cell surface.
E2-BSA is a preparation in which the
ligand is covalently coupled to BSA; thus it
cannot enter the cell and should bind only
to cell surface receptors. This conjugate
was then additionally coupled to fluores-
cein (FITC) for fluorescence microscope
studies. When cells are labeled with this
reagent, the appearance is again punctate,
uneven, and heterogeneous as was shown
for labeling with Cy3-ER Ab (Figure 4).
When these cells are double labeled with
both reagents, exactly the same cells are
labeled with an identical pattern ofstaining
(Figure 6). That these two very different
labeling techniques (one based on epitope
recognition, the other on steroid binding)
label the same cells is very strong evidence
that our immunological identification of
mER is not artifactual.
Figure 6. Simultaneous labeling of cells with E2-BSA in (A) and ER Ab in (B). (C) Shows the bright field image of
the same field. Arrows indicate the labeled cells. Bars = 10 pm.
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RapidResponses toEstrogenAre
DependentonProteins locatedand
ActingattheCellSurface
PRL is released from cells treated with nM
concentrations ofE2 in as rapidly as 1 min.
Such rapid responses are specific for both
17a- and 170-E2, although 17, is more
potent (48). We again used ligands conju-
gated to a large protein molecule (BSA) to
prevent access of our small lipophillic lig-
and to the intracellular space while expos-
ing it to the cell surface. Impeded ligands
therefore represent a way (in addition to
the demonstration of the rapidity of the
response) to suggest that signaling occurs at
a membrane receptor. We applied E2-BSA
to our cell system and assayed PRL release.
Immobilized ligand caused rapid PRL
release from GH3/B6 cells (Figure 1). By 1
min, PRL release in the presence of
5 ng/ml E2-BSA exceeds that ofBSA con-
trols (Figure 4A), though this is not statis-
tically significant (p=0.07). Increased PRL
release is significant at 5 min. Figure 4B
shows that the effect ofE2-BSA is also dose
dependent but is multiphasic, with maxi-
mal stimulation ofPRL release at 1 ng/ml.
The multiphasic aspect ofthe effect reveals
that there maybe a number ofmechanisms
activated by this ligand and that the effec-
tive doses for such alternative mechanisms
may be different. Lieberherr et al. (18)
have shown biphasic effects of E2-BSA on
mobilization ofintracellular calcium in rat
osteoblasts. Although it is difficult to esti-
mate the concentration of estrogen avail-
able to the cells in this reagent (due to
steric considerations), the maximum avail-
able estrogen in 1 ng/ml E2-BSA is 0.3 nM
(given the maximum 20:1 ratio ofestrogen
to BSA in this preparation). Thus, this
reagent is more potent in eliciting PRL
release than is unconjugated 17[-E2. We
are not the first group to see this tethered-
steroid phenomenon. Dluzen and Ramirez
(59) showed that progesterone immobi-
lized on BSA was more potent than free
progesterone in releasing dopamine from
striatal slices. Why the conjugated steroid
is more effective can only be a matter of
speculation at this time since surface recep-
tors represent a new class of steroid-bind-
ing molecules. Estrogen moieties packed
onto a carrier molecule present a higher
local concentration of estrogen to surface
receptors, and a single BSA bearing many
steroid molecules could activate several
clustered surface receptors; clustering of
receptors is important for action in some
signal transduction systems (58). The
covalent attachment of steroid to a large
protein could also prevent the signal from
being processed away and thus circumvent
subsequent down-regulation of the
response. Finally, the 6-substituted E2 may
be a more potent steroid at such a mem-
brane binding site. Alternative ligand
specificities for membrane steroid receptors
have been demonstrated (39,45,60-62).
Trypsin digestion removes membrane
ER labeling (Figure 4C) and therefore
would be expected to affect a function
mediated by this receptor. Figure 2 shows
that trypsin treatment also vitiates the
estrogen-induced PRL release; this result
suggests that the portion ofthe mER corre-
sponding to our antigenic peptide is on the
outside of the cell. Also, because trypsin
has no access to the intracellular receptors,
its action on this antigen supports mem-
brane localization. This action of trypsin
also required us to seek other means of
releasing substrate-attached cells for
immunoselection techniques.
Immunosdection byandRegulaton
ofmERExpression
Since mER is only expressed on a relatively
small percentage ofthe cell population, we
sought a mechanism for purifying and
propagating mER-bearing cells. Figure 7
shows the appearance of cells enriched or
depleted for mER after a representative
immunopanning experiment. In the exper-
iment depicted in Figure 6, 98% of
selected cells (all cells in the shown field)
were enriched for carrying mER (Figure
6A); mER cells were sparsely and weakly
labeled (Figure 6B). In addition, the stain-
ing intensity of mER+ cells is very strong.
Figure 8A shows that the average numbers
of cells immunoselected with either anti-
ER Ab are about 80% positive for mER
compared to about 20% very weakly posi-
tive cells in depleted fractions (refer to
Figure 7 for staining intensity). This result
assures us that the immunopanning
protocols, which were previously designed
and used for mGR-containing cells
(43,45-47,63), are generally applicable to
other plasma membrane-resident steroid
receptors in other cell types.
Figure 8B shows that when cells are
immunopanned (pooled results from both
Abs) and immediately placed in either
DM1 or SSM medium, the expression of
mER 2 days later is dramatically different
between the two groups. Immunoselection
produced high numbers of positively
labeled cells in DM1, while the cells plated
in serum-containing medium show a very
low level ofmER staining, about the same
as seen in mER- cells. This result could
also explain why serum-grown cells do not
display an estrogen-mediated PRL release
(48). Factors in serum (including estro-
gens) may affect mER expression and PRL
release, thus masking the significant
increase due to E2 treatment. Baseline PRL
release in cells grown in serum-containing
medium is very variable; in defined
medium, however, significant 170-E2stim-
ulation is always evident (48). There is also
the possibility that factors in serum such as
steroids may desensitize cells to rapid E2-
mediated effects by downregulating the
amount of ER in the membrane. Dufy et
al. (64) have shown that previous exposure
to E2 (either 17a or 170) suppresses fur-
ther 17[B-E2-stimulated electrophysiologi-
cal effects in GH3/B6 cells.
Figure 8Cshows that immunoseparated
mER+ cells persist in culture over time and
can therefore be propagated to obtain large
numbers of cells for biochemical analysis.
In this study, cells were immunopanned,
propagated for the indicated amount of
time in serum-containing medium, and
then switched back to DM1 2 days before
immunocytochemical analysis. A high per-
centage ofcells still show labeling with ER
Ab for at least 1 month. Although the
trend is for slight loss of mER, the num-
bers are not significantly different from
each other, and Gametchu and coworkers
(unpublished observations) have retained
mGR+ cells for 2 years without reselecting
(although some decline in mGR was
observed). These data also demonstrate the
reversibility ofthe serum effect on mER. In
this way we are able to propagate cells in
serum (in which they grow faster) but
switch them back to defined media for 2
days before immunocytochemistry or other
assays to obtain cells expressing mER.
Figure 3 shows that selection of cell
populations with enhanced mER also
selects cells with an increased ability to
release PRL in response to E2. Cells
depleted for mER are no longer capable of
this response. Our results indicate that a
rapid effect of estrogen on PRL release in
mER-enriched cells is evident by 5 min; we
have shown significant responses in as litde
as 1 min (48). Dufy et al. (64) demon-
strated electrophysiological effects of estro-
gen as early as 1 min in GH3/B6 cells,
while Morley et al. (17) showed increases
in intracellular calcium within 5 sec in
granulosa cells. Previous studies on
GH3/B6 cells reported PRL release in
response to estrogen by 10 min (65). It is
difficult to conceive that a genomic effect
can increase secreted PRL in as rapidly as 1
to 5 min. However, it is known that in GC
cells (another rat pituitary cell line),
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Figure 8. Immunoselection of mER+ cells. (A) Effects of ER Ab (R3 and R4) used for selection. (B) Serum reduces the expression of mER to preselection levels (pooled results
from cells labeled with either R3 or R4 Ab). (C) Immunoseparated mER+ GH3/B6 cells persist over time in culture (pooled results from cells labeled with either R3 or R4 Ab).
*Significantly differentfrom the paired control atthep<0.05 level.**Significantly differentfrom thethree othergroups atthep<0.05 level.
transcription ofendogenous PRL mRNA is
near a maximal rate at this time (66)
although it is not known how soon this is
available for translation. Maurer (67) has
shown that in rat pituitaries, cytoplasmic
PRL mRNA accumulation lags at least 6 hr
behind increases in nuclear mRNA for
PRL. Therefore, the rapidity of our effects
on cells enriched for mER further support a
nongenomic mechanism for this response.
Summary
We believe that these data favor a mem-
brane site ofaction for estrogen in eliciting
the release of PRL from pituitary tumor
cells. The effect is rapid and specific, and
takes place when ligand does not have
access to the intracellular space. The
immunological identification of a mem-
brane-associated ER suggests that this pro-
tein may be mediating rapid PRL release in
GH3/B6 cells. We correlated the quantity
of this antigen on mER-selected GH3/B6
cell populations with the ability of 175-E2
to increase PRL secretion in these cells.
Alternative protein domain function for
steroid receptors residing in different cellu-
lar locations may have relevance to the
pleiotropic expression of receptor muta-
tions and the differential activity ofsteroids
in different tissues or different diseases of
reproduction, metabolism, and estrogen
toxicity. While several systems have been
proposed for assessing the genomic actions
of xenobiotic estrogens (1), a convenient
screening test for nongenomic estrogenic
actions is presently lacking. Further charac-
terization ofour model for rapid estrogen-
induced PRL release from mER-enriched
GH3/B6 cells could make it a system suit-
able for such screening. It will be impor-
tant to consider such a model system to
study the mechanisms of action of estro-
genic compounds among the wide variety
ofenvironmental compounds to which we
are exposed.
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